ABSTRACT
Prior studies suggested that nanoparticle drug delivery might improve the therapeutic response to anticancer drugs and allow the simultaneous monitoring of drug uptake by tumours. Cancer nanotherapeutics are rapidly progressing and are being implemented to solve several limitations of conventional drug delivery systems such as nonspecific bio distribution and targeting, lack of water solubility, poor oral bioavailability, and low therapeutic indices. To improve the biodistribution of cancer drugs, nanoparticles have been designed for optimal size and surface characteristics to increase their circulation time in the bloodstream. They are also able to carry their loaded active drugs to cancer cells by selectively using the unique pathophysiology of tumours, such as their enhanced permeability and retention effect and the tumor microenvironment. In addition to this passive targeting mechanism, active targeting strategies using ligands or antibodies directed against selected tumor targets amplify the specificity of these therapeutic nanoparticles. Drug resistance, another obstacle that impedes the efficacy of both molecularly targeted and conventional chemotherapeutic agents, might also be overcome, or at least reduced, usingnanoparticles. Nanoparticles have the ability to accumulate in cells without being recognized by Pglycoprotein, one of the main mediators of multidrug resistance, resulting in the increased intracellular concentration of drugs. Multifunctional and multiplex nanoparticles are now being actively investigated and are on the horizon as the next generation of nanoparticles, facilitating personalized and tailored cancer treatment.Targeting methotrexate increased its antitumor activity and markedly decreased its toxicity, allowing therapeutic responses not possible with a free drug.
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INTRODUCTION
Nanoparticles are defined as particulate dispersions or solid particles with a size in the range of 10-1000nm. The drug is dissolved, entrapped, encapsulated or attached to a nanoparticle matrix. Depending upon the method of preparation, nanoparticles, nanospheres or nanocapsules can be obtained. Nanocapsules are systems in which the drug is confined to a cavity surrounded by a unique polymer membrane, while nanospheres are matrix systems in which the drug is physically and uniformly dispersed. In recent years, biodegradable polymeric nanoparticles, particularly those coated with hydrophilic polymer such as poly ethylene glycol (PEG) known as long-circulating particles, have been used as potential drug delivery devices because of their ability to circulate for a prolonged period time target a particular organ, as carriers of DNA in gene therapy, and their ability to deliver proteins, peptides and genes. The major goals in designing nanoparticles as a delivery system are to control particle size, surface properties and release of pharmacologically active agents in order to achieve the site-specific action of the drug at the therapeutically optimal rate and dose regimen. Though liposomes have been used as potential carriers with unique advantages including protecting drugs from degradation, targeting to site of action and reduction toxicity or side effects, their applications are limited due to inherent problems such as low encapsulation efficiency, rapid leakage of water-soluble drug in the presence of blood components and poor storage stability. On the other hand, polymeric nanoparticles offer some specific advantages over liposomes. For instance, they help to increase the stability of drugs/proteins and possess useful controlled release properties.
The advantages of using nanoparticles as a drug include the following:
1. Particle size and surface characteristics of nanoparticles can be easily manipulated to achieve both passive and active drug targeting after parenteral administration.
2. They control and sustain release of the drug during the transportation and at the site of localization, altering organ distribution of the drug and subsequent clearance of the drug So as to achieve increase in drug therapeutic efficacy and reduction in side effects. 
Preparation of Nanoparticles
Nanoparticles have been prepared most frequency by three methods:
(1) Dispersion of preformed polymers (2) Polymerization of monomers (3) Ionic gelation or coacervation of hydrophilic polymers.
However, other methods such as supercritical fluid technology and particle replication in non-wetting templates have also been described in the literature for production of nanoparticles. The latter was claimed to have absolute control of particle size, shape and composition, which could set an example for the future mass production of nanoparticles in industry (Van vlerkenet al 2006).
Dispersion of preformed polymers
Dispersion of preformed polymers is a common technique used to prepare biodegradable Nanoparticles from poly lactic acid (PLA), poly glycolic acid(PLG), poly (D, L-lactide-coglycolide) (PLGA) and poly cyanoacrylate (PCA), this technique can be used in various ways as described below (Tice et al 1985) .
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Solvent evaporation method
In this method, the polymer is dissolved in an organic solvent such as dichloromethane, chloroform or ethyl acetate which is also used as the solvent for dissolving the hydrophobic drug. The mixture of polymer and drug solution is then emulsified in an aqueous solution containing a surfactant or emulsifying agent to form an oil in water (o/w) emulsion. After the formation of stable emulsion, the organic solvent is evaporated either by reducing the pressure or by continuous stirring. Particle size was found to be influenced by the type and concentrations of stabilizer, homogenizer speed and polymer concentration. In order to produce small particle size, often a high-speed homogenization or ultrasonication may be employed.
Spontaneous emulsification or solvent diffusion method
This is a modified version of solvent evaporation method. In this method, the water miscible solvent along with a small amount of the water immiscible organic solvent is used as an oil phase. Due to the spontaneous diffusion of solvents an interfacial turbulence is created between the two phases leading to the formation of small particles. As the concentration of water miscible solvent increases, a decrease in the size of particle can be achieved. Both solvent evaporation and solvent diffusion methods can be used for hydrophobic or hydrophilic drugs. In the case of hydrophilic drug, a multiple w/o/w emulsion needs to be formed with the drug dissolved in the internal aqueous phase (Nah J.W.et al2006).
Polymerization method
In this method, monomers are polymerized to form nanoparticles in an aqueous solution.
Drug is incorporated either by being dissolved in the polymerization medium or by adsorption onto the nanoparticles after polymerization completed. The nanoparticle suspension is then purified to remove various stabilizers and surfactants employed for polymerization by ultracentrifugation and re-suspending the particles in an isotonic surfactant-free medium. This technique has been reported for making polybutylcyanoacrylate or poly alkylcyanoacrylatenano particles. Nanocapsule formation and their particle size depends on the concentration of the surfactants and stabilizers used.
Coacervation or ionic gelation method
Much research has been focused on the preparation of nanoparticles using biodegradable 
Examples for ligands
• Folate, Biotin, Thiamine, Transferin(Fenget al 2003).
• Lecithin, Antibodies, Antibody fragments.
• Galactose, Apotamase.
PASSIVE TARGETING:
The surface of the drug or polymer nanoparticle is coated with hydrophilic PEG orPLGA that reduces the hydrophobic interactions with the Reticulo Endothelial system (krang D.M.et al 1995).
• The drug circulates in the blood for a long time.
• E.g. paclitaxil 
Carbon Nanotubes Target Tumor Cells
The Platinum-IV can incorporate into carbon nanotubes which has the capability to attach tumor targeting agent -Folic acid. The carbon nanotubes rapidly enter the target cell. There enzymes within the cell convert Platinum-IV to toxic Platinum-II which reacts with DNA and eventually kills the tumor cell (Hainfeldet al 2005).
Thermal cytotoxicity in malignant cells
The SWNTs targeted to cancer cells may allow noninvasive RF field treatments to produce lethal thermal injury to the malignant cells. The RF field can be used 13.56 megahertz.
Remote magnetic field triggers nanoparticle drug release
To the nanoparticle a short piece of DNA, one or more anticancer drugs were added. The nanoparticle and drugs are complimentarily attached to the DNA. At body temperature, the complimentary strands of DNA form the famous and strong double helix. When the nanoparticle becomes warm as a result of an applied oscillating magnetic field the bonds of DNA become weak and drug molecule diffuses out.
Enhanced cytotoxicity of monoclonal anticancer antibody
Doxorubicin loaded long circulating liposomes were modified with the nucleosome specific monoclonal antibody 2c5(mAb 2c5) as a result higher cytotoxicity towards various cancer cells(Esenalievet al 2005).
Magnetic nanoparticle targeting human cancer cells
Nanoparticles are functionalized with ligands that bind with high affinity to the EphA2 receptor in the ovarian cancer.
Applications of Nanoparticulate Delivery Systems
The rationale of using nanoparticles for tumortargeting is based on 
Long circulating nanoparticles
• To be successful as a drug delivery system, nanoparticles must be able to target tumours which are localized outside MPS-rich organs. In the past decade, a great deal of work has been devoted to developing so-called "stealth Nanoparticles".
• particles or PEGylated nanoparticles, which are invisible to macrophages or phagocytes major breakthrough in the field came when the use of hydrophilic polymers (such as polyethylene glycol, poloxamines, poloxamers, and polysaccharides) to efficiently coat conventional nanoparticle surface produced an opposing effect to the uptake by the MPS.
• These coatings provide a dynamic "cloud" of hydrophilic and neutral chains at the particle surface which repel plasma proteins.
• As a result, those coated nanoparticles become invisible to MPS, therefore, remained in the circulation for a longer period of time. Hydrophilic polymers can be introduced at the surface in two ways, either by adsorption of surfactants or by use of block or branched copolymers for production of nanoparticles.
Full Text Available On www.ijipls.com
• Studies show nanoparticles containing a coat of PEG not only have a prolonged halflife in the blood compartment but also be able to selectively extravasate in pathological sites such as tumours or inflamed regions with a leakyvasculature.
• As a result, such long-circulating nanoparticles have increased the potential to directly target tumors located outside MPS-rich regions.
• The size of the colloidal carriers as well as their surface characteristics are the critical to the biological fate of nanoparticles. A size less than 100 nm and a hydrophilic surface are essential in achieving the reduction of opsonisation reactions and subsequent clearance by macrophages.
• Coating conventional nanoparticles with surfactants or PEG to obtain a longcirculating carrier has now been used as a standard strategy for drug targeting in vivo.
• Extensive efforts have been devoted to achieving "active targeting" of nanoparticles Receptor-mediated endocytosis. The ability to increase oral bioavailability of various peptides(e.g., granulocyte colony stimulating factor, erythropoietin) and particles by covalent coupling to vitamin B-12.For this intrinsic process, mucoprotein is required, which is prepared by the mucus membrane in the stomach and binds specifically to cobalamin. The mucoprotein completely reaches the ileum where resorption is mediated by specific receptors.
Nanoparticles for drug delivery into the brain
The blood-brain barrier (BBB) is the most important factor limiting the development of new Drugs for the central nervous system. The BBB is characterized by relatively impermeable Endothelial cells with tight junctions, enzymatic activity and active efflux transport systems.
It effectively prevents the passage of water-soluble molecules from the blood circulation into the CNS, and can also reduce the brain concentration of lipid-soluble molecules by the function of enzymes or efflux pumps consequently, the BBB only permits selective transport of molecules that are essential for brain function (Bhadra et al 2002) .
CONCLUSION
The foregoing show that nanoparticulate systems have great potentials, being able to convert poorly soluble, poorly absorbed and labile biologically active substance into promising deliverable drugs. The core of this system can enclose a variety of drugs, enzymes, genes and is characterized by a long circulation time due to the hydrophilic shell which prevents recognition by the reticular-endothelial system. To optimize this drug delivery system, greater understanding of the different mechanisms of biological interactions, and particle engineering, is still required. Further advances are needed in order to turn the concept of nanoparticle technology into a realistic practical application as the next generation of drug delivery system.
